Maria Mouktaroudi

1 Rimini Str
Athens, ESYE31 12462, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Hydrogen sulfide to modulate Glycated hemoglobin and gut microbiome in type 2 diabetes mellitus.

Hydrogen sulfide to modulate Glycated hemoglobin and gut microbiome in type 2 diabetes mellitus.

Journal: Metabolism open

Published: September 01, 2025

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.

Journal: The Lancet. Respiratory medicine

Published: July 28, 2023

Clinical evidence supporting ceftaroline fosamil and ceftobiprole for complicated skin and soft tissue infections.

Clinical evidence supporting ceftaroline fosamil and ceftobiprole for complicated skin and soft tissue infections.

Journal: Current opinion in infectious diseases

Published: February 28, 2023

Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae.

Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae.

Journal: Expert review of anti-infective therapy

Published: January 17, 2022

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

Journal: Nature medicine

Published: October 09, 2021

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

Journal: Nature medicine

Published: June 22, 2021

The Association of TSH and Thyroid Hormones With Lymphopenia in Bacterial Sepsis and COVID-19.

The Association of TSH and Thyroid Hormones With Lymphopenia in Bacterial Sepsis and COVID-19.

Journal: The Journal of clinical endocrinology and metabolism

Published: November 25, 2020

Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.

Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.

Journal: Genome medicine

Published: July 15, 2020

Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.

Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.

Journal: Cell host & microbe

Published: April 12, 2020

Diabetes on sepsis outcomes in non-ICU patients: A cohort study and review of the literature.

Diabetes on sepsis outcomes in non-ICU patients: A cohort study and review of the literature.

Journal: Journal of diabetes and its complications

Published: January 14, 2020

Paraneoplastic digital ischemia in clear-cell renal-cell carcinoma: Report of a case and review of the literature.

Paraneoplastic digital ischemia in clear-cell renal-cell carcinoma: Report of a case and review of the literature.

Journal: Urologia

Published: August 22, 2019

Deletion of hematopoietic Dectin-2 or CARD9 does not protect against atherosclerotic plaque formation in hyperlipidemic mice.

Deletion of hematopoietic Dectin-2 or CARD9 does not protect against atherosclerotic plaque formation in hyperlipidemic mice.

Journal: Scientific reports

Published: September 04, 2018

Showing 1-12 of 21

Last Updated: 09/26/2026